The Globe and Mail reports in its Wednesday edition that Raymond James analyst Frederic Bastien has elevated his recommendation for Atkinsrealis Group to "strong buy" from "outperform." The Globe's David Leeder writes in the Eye On Equities column that Mr. Bastien advanced his share target by $20 to $130. Analysts on average target the shares at $118.29. Mr. Bastien says in a note: "Our largely M&A-free forecasts call for a healthy 42-per-cent increase in adjusted EPS over the next two years, with Atkinsrealis Group's two main engines contributing evenly to this growth. While recent speed bumps have raised questions around the ES segment's 8-per-cent organic revenue CAGR target for 2025–2027, a strengthening backlog points to an approaching inflection. We expect the UKI practice's leadership in water to create significant opportunities with the AMP8 investment program, per a recent contract win to provide full multidisciplinary services for Anglian Water Services through 2040. At the same time, an expanding footprint and high-touch client engagement and helping Atkinsrealis grow its share of the USLA and AMEA transportation pies, and a back-to-basics approach is driving similarly encouraging gains in Canada."